Clinical Trial

LDRT Combined With Toripalimab and Chemotherapy for Recurrent/Metastatic NPC

Study acronym: LIGHT
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This study aims to evaluate the efficacy and safety of LDRT combined with toripalimab and GP chemotherapy in patients with recurrent or metastatic nasopharyngeal carcinoma through a prospective, open-label, single-arm Phase II clinical trial.
Protocol Amendment History 3 changes
notable Primary completion pushed: 2026-09-01 -> 2028-01-30 2026-05-02
minor Completion pushed: 2028-06-01 -> 2030-01-30 2026-05-02
critical Recruitment opened 2026-04-14
Trial Details
NCT Number NCT07325539
Lead Sponsor Sun Yat-sen University
Conditions Nasopharyngeal Cancinoma (NPC), Nasopharangeal Cancer
Enrollment 55 participants
Start Date 2026-01-12
Primary Completion 2028-01-30 (estimated)
Study Completion 2030-01-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-22